Live Breaking News & Updates on Biogen Collaboration|Page 8

Stay updated with breaking news from Biogen collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alzheimer's drug adoption in U.S. slowed by doctors' skepticism

There is an entrenched belief among some doctors that treating the memory-robbing disease is futile. ....

United States , Drug Administration ,

Biogen Q1 Adj. EPS Tops Estimates, But Sales Miss; Reaffirms FY24 Outlook

Biotechnology company Biogen Inc. (BIIB) reported Wednesday net income attributable to the company for the first quarter of $393.4 million or $2.70 per share, higher than $387. ....

Thomson Reuters , Biogen Inc , Iotechnology Company Biogen ,

Biogen stock up as sales of Leqembi beat expectations

Biogen's Leqembi, the first drug to slow the progression of Alzheimer's, launched last year ....

United Kingdom , United States , Christopher Viehbacher , Drug Administration , Brian Snyder , Japan Based Eisai , Christopher Viehbacher , Spinal Muscular Atrophy ,

The Dow falls 70 points as Tesla stock can't sustain the market

Meta and IBM will release their quarterly reports after the closing bell ....

United States , United Kingdom , Devin Nunes , Elon Musk , Financial Services , Trump Media Technology Group , Dow Jones Industrial Average , Technology Group , Rocio Fabbro , Trump Media Amp Technology Group , Ruce Gil , Meta Platforms , Elon Musk , William Gavin , Trump Media , Devin Nunes ,

Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue estimate of $9.47 billion. […] ....

United States , William Blair , Priya Singhal , Erick Rowinsky , Biogen Inc , Royal Bank , Jpmorgan Chase Co , Get Free Report , Moderate Buy , Director Eric , Biogen Daily , Nasdaq Biib ,